Omega Healthcare Investors Files 8-K

TL;DR

OHI filed an 8-K on 6/11 for events on 6/10, mostly financial docs.

AI Summary

Omega Healthcare Investors, Inc. filed an 8-K on June 11, 2025, reporting on events that occurred on June 10, 2025. The filing primarily concerns financial statements and exhibits, with no specific material events detailed in the provided text beyond the standard reporting requirements.

Why It Matters

This filing indicates routine corporate reporting, providing updates on financial statements and exhibits for Omega Healthcare Investors, Inc.

Risk Assessment

Risk Level: low — The filing appears to be routine administrative and financial reporting without any disclosed material adverse events.

Key Players & Entities

• Omega Healthcare Investors, Inc. (company) — Registrant

FAQ

From the Filing

0001104659-25-058593.txt : 20250611 0001104659-25-058593.hdr.sgml : 20250611 20250611172959 ACCESSION NUMBER: 0001104659-25-058593 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250610 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250611 DATE AS OF CHANGE: 20250611 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMEGA HEALTHCARE INVESTORS INC CENTRAL INDEX KEY: 0000888491 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction EIN: 383041398 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11316 FILM NUMBER: 251040996 BUSINESS ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 BUSINESS PHONE: 410-427-1700 MAIL ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 8-K 1 tm2517623d1_8k.htm FORM 8-K false 0000888491 0000888491 2025-06-10 2025-06-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549       FORM 8-K       CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): June 10, 2025   OMEGA HEALTHCARE INVESTORS, INC. (Exact name of registrant as specified in its charter)   Maryland 1-11316 38-3041398 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)   303 International Circle Suite 200 Hunt Valley , Maryland 21030 (Address of principal executive offices / Zip Code)   ( 410 ) 427-1700 (Registrant’s telephone number, including area code)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:     ¨ Written communications pursuant to Rule 425 under the Securities Act.     ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act.     ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.     ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.   Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:       Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $.10 par value OHI New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company  ¨   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨           Item 8.01 Other Events.   On June 10, 2025, Omega Healthcare Investors, Inc. (“Omega”) issued a press release announcing the pricing of an underwritten public offering (the “Offering”) of $600,000,000 aggregate principal amount of 5.200% Senior Notes due 2030. The press release announcing the pricing of the Offering is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.    Also on June 10, 2025, Omega entered into an underwriting agreement (the “Underwriting Agreement”) with the representatives of the several underwriters named therein relating to the Offering. The net proceeds from the Offering, a